© Francois Guenet / Inserm
Appointed by the French Council of Ministers on November 26, 2018, Gilles Bloch took up his post as Chairman and Chief Executive Officer of Inserm on January 2, 2019.
A graduate of the École Polytechnique, doctor, and researcher specializing in medical imaging, Gilles Bloch spent a large part of his career at the French Atomic Energy Commission before taking on major roles within research policy, including heading up the French National Research Agency upon its creation, and then being appointed Head of Research and Innovation at the Ministry of Higher Education and Research. Since 2015, he has chaired Université Paris-Saclay.
On the occasion of his new role, Gilles Bloch will present his New Year greetings to the press on Tuesday January 15, 2019 at 9 a.m., at Inserm headquarters.
Press contact and registration: firstname.lastname@example.org
The respective classifications of the European Patent Office (EPO) and France's National Industrial Property Institute (INPI), which have just published their annual rankings for 2017, have confirmed Inserm's ability to innovate. Inserm placed first among patent applicants in the pharmaceutical sector for ...
Le succès d’un engagement sur le long terme de l’Inserm, de Sorbonne Université, du Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts et de la Fondation Voir et Entendre: ces partenaires fondateurs de l’IHU FOReSIGHT s’engagent dans un projet d’exception visant à relever les ...